Magnetar Financial LLC United Therapeutics Corp Transaction History

Magnetar Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $679,225 - $880,706	3,189 New	3,189 $714,000
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $853,422 - $1.18 Million	-4,882 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $559,294 - $720,189	3,366 Added 222.03%	4,882 $876,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $284,405 - $333,411	-1,543 Reduced 50.44%	1,516 $328,000
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $10,971 - $13,107	-61 Reduced 1.96%	3,059 $565,000
Q2 2021 Aug 06, 2021	BUY	$170.47 - $211.93 $531,866 - $661,221	3,120 New	3,120 $560,000
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $1.73 Million - $2.57 Million	-16,940 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $1.69 Million - $2.05 Million	16,940 New	16,940 $1.71 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $195,133 - $224,175	-2,607 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $198,288 - $314,951	2,607 New	2,607 $204,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.